Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29430654)

  • 1. Enhanced efficacy of AZD3759 and radiation on brain metastasis from EGFR mutant non-small cell lung cancer.
    Li X; Wang Y; Wang J; Zhang T; Zheng L; Yang Z; Xing L; Yu J
    Int J Cancer; 2018 Jul; 143(1):212-224. PubMed ID: 29430654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AZD3759 enhances radiation effects in non-small-cell lung cancer by a synergistic blockade of epidermal growth factor receptor and Janus kinase-1.
    Zhao R; Yin W; Yu Q; Mao Y; Deng Q; Zhang K; Ma S
    Bioengineered; 2022 Jan; 13(1):331-344. PubMed ID: 34738874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AZD3759, a BBB-penetrating EGFR inhibitor for the treatment of EGFR mutant NSCLC with CNS metastases.
    Yang Z; Guo Q; Wang Y; Chen K; Zhang L; Cheng Z; Xu Y; Yin X; Bai Y; Rabbie S; Kim DW; Ahn MJ; Yang JC; Zhang X
    Sci Transl Med; 2016 Dec; 8(368):368ra172. PubMed ID: 27928026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study.
    Ahn MJ; Kim DW; Cho BC; Kim SW; Lee JS; Ahn JS; Kim TM; Lin CC; Kim HR; John T; Kao S; Goldman JW; Su WC; Natale R; Rabbie S; Harrop B; Overend P; Yang Z; Yang JC
    Lancet Respir Med; 2017 Nov; 5(11):891-902. PubMed ID: 29056570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osimertinib (AZD9291) increases radio‑sensitivity in EGFR T790M non‑small cell lung cancer.
    Wang N; Wang L; Meng X; Wang J; Zhu L; Liu C; Li S; Zheng L; Yang Z; Xing L; Yu J
    Oncol Rep; 2019 Jan; 41(1):77-86. PubMed ID: 30365094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsp90 inhibitor NVP-AUY922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors.
    Hashida S; Yamamoto H; Shien K; Ohtsuka T; Suzawa K; Maki Y; Furukawa M; Soh J; Asano H; Tsukuda K; Miyoshi S; Kanazawa S; Toyooka S
    Oncol Rep; 2015 Mar; 33(3):1499-504. PubMed ID: 25607753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental study of EGFR-TKI aumolertinib combined with ionizing radiation in EGFR mutated NSCLC brain metastases tumor.
    Zhang Y; Li Y; Han Y; Li M; Li X; Fan F; Liu H; Li S
    Eur J Pharmacol; 2023 Apr; 945():175571. PubMed ID: 36804545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AZD3759 inhibits glioma through the blockade of the epidermal growth factor receptor and Janus kinase pathways.
    Yin W; Zhang K; Deng Q; Yu Q; Mao Y; Zhao R; Ma S
    Bioengineered; 2021 Dec; 12(1):8679-8689. PubMed ID: 34635007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab radiosensitizes non-small cell lung cancer xenografts by inhibiting DNA double-strand break repair in endothelial cells.
    Gao H; Xue J; Zhou L; Lan J; He J; Na F; Yang L; Deng L; Lu Y
    Cancer Lett; 2015 Aug; 365(1):79-88. PubMed ID: 25982206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP Inhibitors.
    Parsels LA; Karnak D; Parsels JD; Zhang Q; Vélez-Padilla J; Reichert ZR; Wahl DR; Maybaum J; O'Connor MJ; Lawrence TS; Morgan MA
    Mol Cancer Res; 2018 Feb; 16(2):222-232. PubMed ID: 29133592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer.
    Reda M; Ngamcherdtrakul W; Gu S; Bejan DS; Siriwon N; Gray JW; Yantasee W
    Cancer Lett; 2019 Dec; 467():9-18. PubMed ID: 31563561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of epidermal growth factor receptor-tyrosine kinase inhibitors alone on EGFR-mutant non-small cell lung cancer with brain metastasis.
    Zhang Q; Zhang X; Yan H; Jiang B; Xu C; Yang J; Chen Z; Su J; Wu YL; Zhou Q
    Thorac Cancer; 2016 Nov; 7(6):648-654. PubMed ID: 27755835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR tyrosine kinase inhibitors versus cranial radiation therapy for EGFR mutant non-small cell lung cancer with brain metastases: a systematic review and meta-analysis.
    Soon YY; Leong CN; Koh WY; Tham IW
    Radiother Oncol; 2015 Feb; 114(2):167-72. PubMed ID: 25583566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis.
    Byeon S; Ham JS; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
    Med Oncol; 2016 Aug; 33(8):97. PubMed ID: 27447711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs.
    Gui Q; Liu J; Li D; Xu C
    World J Surg Oncol; 2017 Oct; 15(1):184. PubMed ID: 29037198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coadministration of Trametinib and Palbociclib Radiosensitizes KRAS-Mutant Non-Small Cell Lung Cancers In Vitro and In Vivo.
    Tao Z; Le Blanc JM; Wang C; Zhan T; Zhuang H; Wang P; Yuan Z; Lu B
    Clin Cancer Res; 2016 Jan; 22(1):122-33. PubMed ID: 26728409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment options for EGFR mutant NSCLC with CNS involvement-Can patients BLOOM with the use of next generation EGFR TKIs?
    Tan CS; Cho BC; Soo RA
    Lung Cancer; 2017 Jun; 108():29-37. PubMed ID: 28625644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic modelling of resistance to epidermal growth factor receptor inhibition in brain metastasis mouse models.
    Martin EC; Aarons L; Yates JWT
    Cancer Chemother Pharmacol; 2018 Oct; 82(4):669-675. PubMed ID: 30054711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mangiferin induces radiosensitization in glioblastoma cells by inhibiting nonhomologous end joining.
    Mu F; Liu T; Zheng H; Xie X; Lei T; He X; Du S; Tong R; Wang Y
    Oncol Rep; 2018 Dec; 40(6):3663-3673. PubMed ID: 30272350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allyl isothiocyanate induces replication-associated DNA damage response in NSCLC cells and sensitizes to ionizing radiation.
    Tripathi K; Hussein UK; Anupalli R; Barnett R; Bachaboina L; Scalici J; Rocconi RP; Owen LB; Piazza GA; Palle K
    Oncotarget; 2015 Mar; 6(7):5237-52. PubMed ID: 25742788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.